Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02628 |
| Species: | Mus musculus |
| Position : | chr17:63643401-63643706 |
| Year: | 2022 |
| Title: | Hnf1b renal expression directed by a distal enhancer responsive to Pax8. |
| Genome Build: | mm10 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 36402859 |
| Tissue: | kidney |
| Tissue Ontology ID: | UBERON:0002113 |
| Cell Source: | mIMCD3 |
| Cell Type: | kidney epithelial cell |
| Cell Ontology ID: | CL:0002518 |
| Experiment Type: | Enhancer activity assay; TF binding assay; Functional perturbation assay; In vivo enhancer editing |
| High Throughput Method: | ATAC-seq; ChIP-seq; DNase-seq |
| Low Throughput Method: | Luciferase reporter assay; Pax8-site mutagenesis; CRISPR-Cas9 enhancer editing; RT-qPCR; in vivo Xenopus reporter assay |
| Target gene : | Hnf1b |
| TF name : | Pax8 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| Pax8 | ID | netpath | 38 |
| Pax8 | Pathways in cancer | kegg | 321 |
| Pax8 | Thyroid cancer | kegg | 25 |
| Pax8 | Hs_Thyroid_Stimulating_Hormone_(TSH)_signaling_pathway_WP2032_89823 | wikipathways | 28 |